GOOD READS

Acadia Medical (ACHC): Zacks Rank Buy

RELATED QUOTES

SymbolPriceChange
ACHC40.22+0.01

Shares of Acadia Medical (ACHC) reached a 52-week high of $25.76 on January 8 following its accretive acquisition of Greenleaf Center a day earlier. Several strategic investments of late and impressive fiscal third-quarter results helped this healthcare services provider become a Zacks Rank #1 (Strong Buy).

The company has delivered an average earnings surprise of 16.7% over the past four quarters, including a 13.3% beat in the third quarter. Given its expected long-term earnings growth rate of 29.0%, this stock looks like it would fit well into the portfolio of a growth seeking investor.

Rank Drivers

On November 6, 2012, Acadia Medical reported fiscal third quarter adjusted earnings per share (EPS) of 17 cents, beating the Zacks Consensus Estimate by 13.3%. However, the result fell short of the year-ago performance due to an increase in its shares outstanding, completion of the PHC Inc. acquisition in November 2011 and an increase in interest expenses.

On January 7, 2013, Acadia Medical purchased Greenleaf Center, a 50-bed acute inpatient psychiatric facility in Georgia, from South Georgia Medical Center. The company noted that Greenleaf, which has $7 million of annual revenues, will remain accretive to its 2013 EPS.

Recently, Acadia Medical has made several strategic acquisitions, including Behavioral Centers of America and AmiCare Behavioral Centers on December 31, 2013. In November, it purchased Park Royal Hospital, a 76-bed acute inpatient psychiatric hospital in Florida.

Also in November, the company declared its intention to buy Arkansas based AmiCare Behavioral Centers, which operates four inpatient psychiatric facilities. Management expects this transaction to be accretive to its 2013 financial results. The company is greatly optimistic about these recent developments, which are expected to act as major catalysts for future growth.

Earnings Estimates Moving Up

The Zacks Consensus Estimate for 2012 is 64 cents, up about 23.8% year over year. Meanwhile, over the past 30 days, the Zacks Consensus Estimate for 2013 gained 4.3% to 98 cents per share, representing year-over-year growth of about 52.9%.

Premium Valuation

Acadia Medical's valuation looks stretched compared to its peers by most metrics. Based on the 2012 earnings estimate, the company is trading at a P/E of 25.21x, which is almost 1.7 times the peer group average of 16.63x. The price-to-book ratio of 4.10x is also substantially higher than the peer group average of 2.10x. The premium is warranted given a higher long-term earnings growth rate of 29.0%, compared with the industry average 12.7%.

However, with respect to return on assets (:ROA), Acadia Medical looks attractive at 3.9%, a marginal premium to the peer group average of 3.5%.

Acadia's price performance has been reasonably strong. Following the release of its fiscal third-quarter results, the stock showed a steep uptrend and is currently trading above both its 50- and 200-day averages.

Acadia Medical is a provider of inpatient behavioral healthcare services. As of September 30, 2012, the company operates a network of 33 behavioral health facilities with over 2,300 licensed beds in 19 states. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. The company has a market cap of $1.04 billion.

Other Zacks #1 Rank (Strong Buy) medical devices stocks include Spherix Inc. (SPEX) and Syneron Medical Ltd (ELOS).


Want More of Our Best Recommendations?

Zacks' Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Then each week he hand-selects the most compelling trades and serves them up to you in a new program called Zacks Confidential.

Learn More>>


ACADIA HEALTHCR (ACHC): Free Stock Analysis Report

Zacks Investment Research



More From Zacks.com

Quiz: How well do you know India's economy?

Question 1

Which of these products is India the world's largest producer of?

Poll Choice Options
  • Wheat
  • Rice
  • Milk
1
2
3
4
5
6
7
8
9
10

Latest News

  • Strides surges as Bangalore plant remains U.S. FDA compliant

    Reuters Market Eye - Strides Arcolab surges 6.3 percent after the drugmaker said on Friday its oral drug manufacturing facility in Bangalore continues to maintain compliance with the manufacturing standards of the U.S. health regulator. "U.S. FDA recently inspected this facility as part of GMP compliance audit and raised Form 483 (inspection observations) during the Dec 2013 inspection (which has now been satisfactorily closed)," Macquarie said in a note to its clients. This is a key positive …

  • French companies to continue investing around $1 bn in India

    New Delhi, April 25 (IANS) Expressing confidence in the Indian economy, French companies that are engaged in India will continue to annually invest nearly $1 billion here as they see long-term future in the country's growth potential, a top diplomat has said. "I expect the investment trend of nearly a billion dollars to continue as the French companies are here for the long-term and are setting up their base here and expanding production," French Ambassador François Richier told IANS in an …

  • `India needs over 26,000 independent directors'

    Kochi, April 25 (IANS) India needs over 26,000 independent directors and around 2,500 women directors to fill the boards of companies across the country, an official said here Friday. Lt. Gen (Retd) J.S. Ahluwalia, president of the Institute of Directors, said that despite a handful of high profile female Indian entrepreneurs, the proportion of female directors is a meagre 5.2 percent, which is even below the developing world percentage of 7.2 percent. Ahluwalia's statement comes at a time …

  • India's growth prospects dim regardless of election outcome - Reuters  …

    Prospects for a strong economic rebound in India are dim as industry remains weak, and although a business-friendly opposition party looks likely to form a new government, its ability to pass sweeping reforms is in doubt, a Reuters poll showed. An anticipated victory for the Bharatiya Janata Party's (BJP) at the conclusion next month of an ongoing election in the world's largest democracy has pushed India's stock market to a record high. Anubhuti Sahay, senior economist at Standard Chartered …

  • World shares, dollar struggle on Ukraine anxiety

    Heightened tension in Ukraine pushed world shares lower and lifted safe-haven European bonds on Friday, taking the shine off what looked set to be an earnings and M&A-driven week of gains for European and U.S. stocks. Trouble in Ukraine escalated after Ukrainian forces killed up to five pro-Russia separatists on Thursday and Russia conducted military drills near the border, raising fears it was gearing up to invade. European shares tumbled 0.5 percent in early trading as concerns also rose …

IN-DEPTH ANALYSIS & INTERVIEWS

  • Too good to be true?

    Developers are offering lucrative buyback schemes. But such promises may not be always kept. …

  • Leaderspeak with Vikram Limaye

    Vikram Limaye MD & CEO, IDFC Ltd shares many firsts from his life. …

  • The Greening of the House of Tatas

    How a dedicated team converted a 90-year-old heritage structure into a benchmark for environment-friendly buildings. …

  • Appy Voting

    Mobile and online apps, seeking to inform or influence voters, have been more active than ever before in this election. …

  • In the crosshairs

    Why the future of FDI in multi-brand retail looks bleak after the polls. …

  • Deserving the honour

    How do the winners of the two new banking licences - microfinance lender Bandhan Financial Services and infra institution IDFC Ltd - measure up to the challenges of operating as full-fledged banks? …

  • A Samurai from Chandigarh

    Advertising veteran Sandeep Goyal is disarmingly frank as he recounts his years with Dentsu. …

MARKET MOVERS

  • Most Actives
    Most Actives
    NamePriceChange% Chg
    23.45-0.40-1.68%
    ASHOKLEY.BO
    16.47-0.05-0.30%
    UNITECH.BO
    129.75+9.35+7.77%
    FRL.BO
    75.80+3.50+4.84%
    HDIL.BO
    116.700.000.00%
    IDFCSL.BO
  • Price % Gainers
    Price % Gainers
    NamePriceChange% Chg
    12.51+2.00+19.03%
    BIBCL.BO
    553.80+87.80+18.84%
    STRIDES.BO
    261.45+31.40+13.65%
    VIVIMEDLABS.BO
    163.75+20.05+13.95%
    AGARIND.BO
    31.85+4.00+14.36%
    STOREONE.BO
  • Price % Losers
    Price % Losers
    NamePriceChange% Chg
    -10.95-100.00%
    4THGEN.BO
    -17.30-100.00%
    ALFAICA.BO
    -17.65-100.00%
    AMAL.BO
    -12.31-100.00%
    BORAX.BO
    -29.95-100.00%
    BRADYM.BO
  •  
    Recent Quotes
    Symbol Price Change % ChgChart 
    Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.
    You need to enable your browser cookies to view your most recent quotes.
  • Recent Quotes News

    •  
      Sign-in to view quotes in your portfolios.